TriSalus Life Sciences (NASDAQ:TLSIW) Stock Price Down 10.8% – What’s Next?

TriSalus Life Sciences, Inc. (NASDAQ:TLSIW)’s share price dropped 10.8% on Tuesday . The company traded as low as $1.29 and last traded at $1.29. Approximately 9,259 shares traded hands during trading, an increase of 32% from the average daily volume of 7,031 shares. The stock had previously closed at $1.4455.

TriSalus Life Sciences Stock Down 10.8%

The firm’s 50-day simple moving average is $1.46 and its 200-day simple moving average is $1.44.

Institutional Trading of TriSalus Life Sciences

Several hedge funds have recently modified their holdings of the stock. Cerity Partners LLC bought a new stake in shares of TriSalus Life Sciences during the fourth quarter worth approximately $1,374,000. Citadel Advisors LLC raised its position in shares of TriSalus Life Sciences by 439.0% during the third quarter. Citadel Advisors LLC now owns 126,876 shares of the company’s stock worth $199,000 after purchasing an additional 103,336 shares during the period. Aristeia Capital L.L.C. bought a new position in TriSalus Life Sciences in the fourth quarter valued at approximately $43,000. Finally, Fort Baker Capital Management LP bought a new stake in TriSalus Life Sciences in the 4th quarter valued at $44,000.

About TriSalus Life Sciences

TriSalus Life Sciences, Inc is a clinical-stage medical device company focused on developing minimally invasive technologies to enhance the precision and efficacy of cancer radiation therapy. The company’s lead product, the TriMark™ Tissue Marker System, is designed to provide high-visibility soft-tissue fiducial markers that assist oncologists in accurately targeting tumors during radiotherapy. By deploying bio-absorbable markers directly into tumor beds, TriSalus aims to improve treatment planning, patient comfort and long-term follow-up imaging.

Founded in 2015 and headquartered in Plymouth, Minnesota, TriSalus Life Sciences pursues a platform approach to oncology treatment, with research and development efforts centered on novel delivery devices and advanced imaging solutions.